22 related articles for article (PubMed ID: 20868233)
1. Molecular determinants and intracellular targets of taurine signalling in pancreatic islet β-cells.
Turbitt J; Moffett RC; Brennan L; Johnson PRV; Flatt PR; McClenaghan NH; Tarasov AI
Acta Physiol (Oxf); 2024 Mar; 240(3):e14101. PubMed ID: 38243723
[TBL] [Abstract][Full Text] [Related]
2. Metformin and Glucose Concentration as Limiting Factors in Retinal Pigment Epithelial Cell Viability and Proliferation.
Villa-Fernández E; García AV; Fernández-Fernández A; García-Villarino M; Ares-Blanco J; Pujante P; González-Vidal T; Fraga MF; Torre EM; Delgado E; Lambert C
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473884
[TBL] [Abstract][Full Text] [Related]
3. [Imeglimin: features of the mechanism of action and potential benefits].
Kuznetsov KO; Saetova AA; Mahmutova EI; Bobrik AG; Bobrik DV; Nagaev IR; Khamitova AD; Arapieva AM
Probl Endokrinol (Mosk); 2022 Mar; 68(3):57-66. PubMed ID: 35841169
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of Imeglimin: A novel therapeutic agent for type 2 diabetes.
Hallakou-Bozec S; Vial G; Kergoat M; Fouqueray P; Bolze S; Borel AL; Fontaine E; Moller DE
Diabetes Obes Metab; 2021 Mar; 23(3):664-673. PubMed ID: 33269554
[TBL] [Abstract][Full Text] [Related]
5. Acute and long-term effects of peroxisome proliferator-activated receptor-γ activation on the function and insulin secretory responsiveness of clonal beta-cells.
Irwin N; McKinney JM; Bailey CJ; McClenaghan NH; Flatt PR
Horm Metab Res; 2011 Apr; 43(4):244-9. PubMed ID: 21165811
[TBL] [Abstract][Full Text] [Related]
6. Effects of chronic exposure of clonal β-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1.
Pathak V; Vasu S; Flatt PR; Irwin N
Diabetes Obes Metab; 2014 Apr; 16(4):357-65. PubMed ID: 24164718
[TBL] [Abstract][Full Text] [Related]
7. Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells.
Patanè G; Piro S; Rabuazzo AM; Anello M; Vigneri R; Purrello F
Diabetes; 2000 May; 49(5):735-40. PubMed ID: 10905481
[TBL] [Abstract][Full Text] [Related]
8. Prolonged exposure to homocysteine results in diminished but reversible pancreatic beta-cell responsiveness to insulinotropic agents.
Patterson S; Scullion SM; McCluskey JT; Flatt PR; McClenaghan NH
Diabetes Metab Res Rev; 2007 May; 23(4):324-34. PubMed ID: 17089371
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice.
McKillop AM; Moran BM; Abdel-Wahab YH; Flatt PR
Br J Pharmacol; 2013 Nov; 170(5):978-90. PubMed ID: 23992544
[TBL] [Abstract][Full Text] [Related]
10. Acute and long-term effects of metformin on the function and insulin secretory responsiveness of clonal β-cells.
McKiney JM; Irwin N; Flatt PR; Bailey CJ; McClenaghan NH
Biol Chem; 2010 Dec; 391(12):1451-9. PubMed ID: 20868233
[TBL] [Abstract][Full Text] [Related]
11. Role of AMPK in pancreatic beta cell function.
Fu A; Eberhard CE; Screaton RA
Mol Cell Endocrinol; 2013 Feb; 366(2):127-34. PubMed ID: 22766107
[TBL] [Abstract][Full Text] [Related]
12. [Insulin oscillations--clinically important rhythm. Antidiabetics should increase the pulsative component of the insulin release].
Hellman B; Gylfe E; Grapengiesser E; Dansk H; Salehi A
Lakartidningen; 2007 Aug 8-21; 104(32-33):2236-9. PubMed ID: 17822201
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]